Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ELK4 Promotes Colorectal Cancer Progression by Activating the Neoangiogenic Factor LRG1 in a Noncanonical SP1/3-Dependent Manner. | Adv Sci (Weinh) | 2023 | 37786278 | PubTator, text mining | PubMed |
| Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities. | Front Immunol | 2023 | 37744371 | PubTator, text mining | PubMed |
| Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options. | Drugs | 2023 | 37737434 | PubTator, text mining | PubMed |
| The future of affordable cancer immunotherapy. | Front Immunol | 2023 | 37736099 | PubTator, text mining | PubMed |
| Current advances in cancer vaccines targeting NY-ESO-1 for solid cancer treatment. | Front Immunol | 2023 | 37731507 | PubTator, text mining | PubMed |
| mRNA vaccines in disease prevention and treatment. | Signal Transduct Target Ther | 2023 | 37726283 | PubTator, text mining | PubMed |
| A tumor-associated endothelial signature score model in immunotherapy and prognosis across pan-cancers. | Front Pharmacol | 2023 | 37719845 | PubTator, text mining | PubMed |
| Prediction of survival and immunotherapy response by the combined classifier of G protein-coupled receptors and tumor microenvironment in melanoma. | Eur J Med Res | 2023 | 37716991 | PubTator, text mining | PubMed |
| A robust deep learning workflow to predict CD8 + T-cell epitopes. | Genome Med | 2023 | 37705109 | PubTator, text mining | PubMed |
| Cancer Vaccine Therapeutics: Limitations and Effectiveness-A Literature Review. | Cells | 2023 | 37681891 | PubTator, text mining | PubMed |
| Mutational signatures and their association with survival and gene expression in urological carcinomas. | Neoplasia | 2023 | 37678146 | PubTator, text mining | PubMed |
| Developments in targeted therapy & immunotherapy-how non-small cell lung cancer management will change in the next decade: a narrative review. | Ann Transl Med | 2023 | 37675321 | PubTator, text mining | PubMed |
| Clinically conserved genomic subtypes of gastric adenocarcinoma. | Mol Cancer | 2023 | 37674200 | PubTator, text mining | PubMed |
| Immune checkpoints and cancer immunotherapies: insights into newly potential receptors and ligands. | Ther Adv Vaccines Immunother | 2023 | 37662491 | PubTator, text mining | PubMed |
| Genome instability-derived genes as a novel prognostic signature for lung adenocarcinoma. | Front Cell Dev Biol | 2023 | 37655157 | PubTator, text mining | PubMed |
| Peptide-based vaccine for cancer therapies. | Front Immunol | 2023 | 37654484 | PubTator, text mining | PubMed |
| Global analysis of HLA-A2 restricted MAGE-A3 tumor antigen epitopes and corresponding TCRs in non-small cell lung cancer. | Theranostics | 2023 | 37649599 | PubTator, text mining | PubMed |
| The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells. | Mol Cancer | 2023 | 37649123 | PubTator, text mining | PubMed |
| Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends. | Signal Transduct Target Ther | 2023 | 37635168 | PubTator, text mining | PubMed |
| Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy. | Int J Mol Sci | 2023 | 37629147 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=9